Unicorn Biotechnologies
PrivateLast Round
Seed
Apr 21, 2022
Total Funding Raised
$3.2M
Company Overview
Unicorn Biotechnologies operates in Healthcare & Life Sciences and is based in Sheffield. Its latest recorded funding round was a Seed round in April 2022.
Unicorn Biotechnologies is a biotechnology company that develops automated biomanufacturing platforms and robotic systems to standardize and scale cell culture workflows for the cultivated meat and cell therapy industries.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Industrial Robotics, Smart Manufacturing, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unicorn Biotechnologies Comparables
Compare Unicorn Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scinus Cell Expansion | 84% | |
| Astraveus | 83% | |
| InFamily Foods | 81% |
For institutional investors. Book with your work email.
Unicorn Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 21, 2022 | ||||
| Pre Seed | Aug 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Unicorn Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CULT Food Science | Seed |
| Verve Ventures | Seed |
| C3 | Seed |
| Acequia Capital | Seed |
| Marinya Capital | Seed |
| Curiosity Venture Capital | Seed |
| Karma Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 85% MoM, reaching 4K.
- Apr 21, 2022
$3.2M round led by Acequia Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 2, 2026
Unicorn Biotechnologies Ltd. is to develop and supply a 'self-driving' bioproduction system tailored for Erythroid Culture and smart red blood cell development in United Kingdom on Oct 2nd '26.
For institutional investors. Book with your work email.
Unicorn Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Unicorn Biotechnologies's valuation, stock price, and market status.
Is Unicorn Biotechnologies a public or private company?
Unicorn Biotechnologies is a private company.
What is the current stock price of Unicorn Biotechnologies?
Unicorn Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Unicorn Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unicorn Biotechnologies worth (valuation)?
Valuation information for Unicorn Biotechnologies is not publicly available.
Can I buy Unicorn Biotechnologies stock?
Unicorn Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unicorn Biotechnologies's last funding round?
Unicorn Biotechnologies's most recent funding round was Seed on April 21, 2022.
Who are the main investors in Unicorn Biotechnologies?
Key investors in Unicorn Biotechnologies include Acequia Capital.
Will Unicorn Biotechnologies IPO soon?
No public IPO plans have been announced for Unicorn Biotechnologies.
How can I track Unicorn Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Unicorn Biotechnologies's shares on secondary markets.